Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Xiaoling Yu's publication output changed over time?
ScholarIQpublication output · 2003–2022
Output grew0% over the shown period — from 1 works in 2003 to 1 in 2022.
1
1
1
1
1
1
1
1
1
1
2003200520082009201020122016201720212022
What are the most-cited papers on Xiaoling Yu?
ScholarIQmost cited works
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Fubo Zhou, Wenting Shang, Xiaoling Yu, Jie Tian
S22382660. 2017404 Citations
Malignant Liver Tumors: Treatment with Percutaneous Microwave Ablation—Complications among Cohort of 1136 Patients
Ping Liang, Yang Wang, Xiaoling Yu, Baowei Dong
S50280174. 2009382 Citations
Prognostic Factors for Survival in Patients with Hepatocellular Carcinoma after Percutaneous Microwave Ablation
Ping Liang, Baowei Dong, Xiaoling Yu, Dejiang Yu, Yang Wang, Lei Feng, Qiujin Xiao
S50280174. 2005233 Citations
<b>Percutaneous Sonographically Guided Microwave Coagulation Therapy for Hepatocellular Carcinoma:</b> Results in 234 Patients
Baowei Dong, Ping Liang, Xiaoling Yu, Li Su, Dejiang Yu, Zhigang Cheng, Jing Zhang
S161085503. 2003223 Citations
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Jie Yu, Xiaoling Yu, Zhiyu Han, Zhigang Cheng, Fangyi Liu, Hongyan Zhai, Mengjuan Mu, Yanmei Liu, Ping Liang
Gut. 2016202 CitationsOPEN ACCESS
Related on ScholarIQ
Fujian Medical University
Institution
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Paper
Malignant Liver Tumors: Treatment with Percutaneous Microwave Ablation—Complications among Cohort of 1136 Patients
Paper
Prognostic Factors for Survival in Patients with Hepatocellular Carcinoma after Percutaneous Microwave Ablation
Paper
<b>Percutaneous Sonographically Guided Microwave Coagulation Therapy for Hepatocellular Carcinoma:</b> Results in 234 Patients
Paper
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Paper